NCT04635631 2023-10-10STUDY OF TALAZOPARIB MONOTHERAPY IN CHINESE PARTICIPANTS WITH ADVANCED SOLID TUMORSPfizerPhase 1 Completed15 enrolled 38 charts
NCT02921919 2022-08-24Open-Label Extension and Safety Study of TalazoparibPfizerPhase 2 Completed120 enrolled 16 charts